BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21851602)

  • 1. Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population.
    Stingl JC; Ettrich T; Muche R; Wiedom M; Brockmöller J; Seeringer A; Seufferlein T
    BMC Cancer; 2011 Aug; 11():360. PubMed ID: 21851602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study.
    Shimizu M; Fukutomi Y; Ninomiya M; Nagura K; Kato T; Araki H; Suganuma M; Fujiki H; Moriwaki H
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3020-5. PubMed ID: 18990744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.
    Higurashi T; Hosono K; Takahashi H; Komiya Y; Umezawa S; Sakai E; Uchiyama T; Taniguchi L; Hata Y; Uchiyama S; Hattori A; Nagase H; Kessoku T; Arimoto J; Matsuhashi N; Inayama Y; Yamanaka S; Taguri M; Nakajima A
    Lancet Oncol; 2016 Apr; 17(4):475-483. PubMed ID: 26947328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green tea extracts for the prevention of metachronous colorectal polyps among patients who underwent endoscopic removal of colorectal adenomas: A randomized clinical trial.
    Shin CM; Lee DH; Seo AY; Lee HJ; Kim SB; Son WC; Kim YK; Lee SJ; Park SH; Kim N; Park YS; Yoon H
    Clin Nutr; 2018 Apr; 37(2):452-458. PubMed ID: 28209333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study.
    Chen YX; Gao QY; Zou TH; Wang BM; Liu SD; Sheng JQ; Ren JL; Zou XP; Liu ZJ; Song YY; Xiao B; Sun XM; Dou XT; Cao HL; Yang XN; Li N; Kang Q; Zhu W; Xu HZ; Chen HM; Cao XC; Fang JY
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):267-275. PubMed ID: 31926918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial.
    Jaszewski R; Misra S; Tobi M; Ullah N; Naumoff JA; Kucuk O; Levi E; Axelrod BN; Patel BB; Majumdar AP
    World J Gastroenterol; 2008 Jul; 14(28):4492-8. PubMed ID: 18680228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial.
    Chen IJ; Liu CY; Chiu JP; Hsu CH
    Clin Nutr; 2016 Jun; 35(3):592-9. PubMed ID: 26093535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green Tea Extract to Prevent Colorectal Adenomas, Results of a Randomized, Placebo-Controlled Clinical Trial.
    Seufferlein T; Ettrich TJ; Menzler S; Messmann H; Kleber G; Zipprich A; Frank-Gleich S; Algül H; Metter K; Odemar F; Heuer T; Hügle U; Behrens R; Berger AW; Scholl C; Schneider KL; Perkhofer L; Rohlmann F; Muche R; Stingl JC
    Am J Gastroenterol; 2022 Jun; 117(6):884-894. PubMed ID: 35213393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
    Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
    Trials; 2013 Jul; 14():237. PubMed ID: 23895505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of green tea catechin extract on serum lipids in postmenopausal women: a randomized, placebo-controlled clinical trial.
    Samavat H; Newman AR; Wang R; Yuan JM; Wu AH; Kurzer MS
    Am J Clin Nutr; 2016 Dec; 104(6):1671-1682. PubMed ID: 27806972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia.
    Sinicrope FA; Viggiano TR; Buttar NS; Song LMWK; Schroeder KW; Kraichely RE; Larson MV; Sedlack RE; Kisiel JB; Gostout CJ; Kalaiger AM; Patai ÁV; Della'Zanna G; Umar A; Limburg PJ; Meyers JP; Foster NR; Yang CS; Sontag S
    Cancer Prev Res (Phila); 2021 May; 14(5):573-580. PubMed ID: 33648940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial.
    Dostal AM; Samavat H; Bedell S; Torkelson C; Wang R; Swenson K; Le C; Wu AH; Ursin G; Yuan JM; Kurzer MS
    Food Chem Toxicol; 2015 Sep; 83():26-35. PubMed ID: 26051348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Supplementation of Green Tea Extract Does Not Modify Adiposity or Bone Mineral Density in a Randomized Trial of Overweight and Obese Postmenopausal Women.
    Dostal AM; Arikawa A; Espejo L; Kurzer MS
    J Nutr; 2016 Feb; 146(2):256-64. PubMed ID: 26701796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.
    Hull MA; Sprange K; Hepburn T; Tan W; Shafayat A; Rees CJ; Clifford G; Logan RF; Loadman PM; Williams EA; Whitham D; Montgomery AA;
    Lancet; 2018 Dec; 392(10164):2583-2594. PubMed ID: 30466866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.
    Chow HH; Cai Y; Hakim IA; Crowell JA; Shahi F; Brooks CA; Dorr RT; Hara Y; Alberts DS
    Clin Cancer Res; 2003 Aug; 9(9):3312-9. PubMed ID: 12960117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decaffeinated green tea extract rich in epigallocatechin-3-gallate improves insulin resistance and metabolic profiles in normolipidic diet--but not high-fat diet-fed mice.
    Santana A; Santamarina A; Souza G; Mennitti L; Okuda M; Venancio D; Seelaender M; do Nascimento CO; Ribeiro E; Lira F; Oyama L
    J Nutr Biochem; 2015 Sep; 26(9):893-902. PubMed ID: 26048201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute neurocognitive effects of epigallocatechin gallate (EGCG).
    Scholey A; Downey LA; Ciorciari J; Pipingas A; Nolidin K; Finn M; Wines M; Catchlove S; Terrens A; Barlow E; Gordon L; Stough C
    Appetite; 2012 Apr; 58(2):767-70. PubMed ID: 22127270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Green tea extract and its major constituent epigallocatechin-3-gallate inhibit growth and halitosis-related properties of Solobacterium moorei.
    Morin MP; Bedran TB; Fournier-Larente J; Haas B; Azelmat J; Grenier D
    BMC Complement Altern Med; 2015 Mar; 15():48. PubMed ID: 25880992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does supplementation with green tea extract improve acne in post-adolescent women? A randomized, double-blind, and placebo-controlled clinical trial.
    Lu PH; Hsu CH
    Complement Ther Med; 2016 Apr; 25():159-63. PubMed ID: 27062963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.